A national risk model that gauges a woman's chance of developing breast cancer has been refined to give a more accurate assessment. The revised figures, based on data from more than one million patients, reveal a 300 percent ...
Aug 19, 2015
0
21
Nerve mapping technology allows surgeons to determine whether surgery has been effective for relieving pressure from compressed nerves, which often function poorly and cause sciatica or pain and weakness in muscles supplied ...
Mar 22, 2013
0
0
When it comes to visibility, radiologists, in many cases, are out of sight.
Nov 22, 2016
0
3
Testing for the presence of specific molecules present in the urine of pregnant women can give an indication in early pregnancy of whether a baby will be born premature or the fetus will suffer poor growth, according to research ...
Jul 10, 2014
0
0
MIPT scientists together with their colleagues from St. Petersburg and Israel have analyzed more than 500 previously published scientific articles and proposed their own approach to the choice of methods used for the treatment ...
Feb 10, 2016
0
2
(HealthDay)—The risks of developing an ipsilateral breast event (IBE) and an invasive IBE increased over time for patients with ductal carcinoma in situ (DCIS) who were selected on the basis of favorable clinical and pathologic ...
Sep 17, 2015
0
18
Compared with receiving chemotherapy alone, women with breast cancer who also received the hormonal drug triptorelin to achieve ovarian suppression had a higher long-term probability of ovarian function recovery, without ...
Dec 22, 2015
0
2
There is a relative increase of 20% to 30% in breast cancer risk associated with both combined and progestogen-only contraceptives, whatever the mode of delivery, though with five years of use, the 15-year absolute excess ...
Mar 21, 2023
0
50
Approximately 20 million Americans will experience some type of gastroesophageal reflux disease, or GERD, in their lives. In some cases, patients suffer resulting heart burn or acid regurgitation so severe that they require ...
Sep 29, 2015
0
17
(HealthDay)—For women with early-stage, hormone receptor-positive invasive breast cancer, initiation of cholesterol-lowering medication (CLM) during endocrine therapy is associated with improved survival and distant recurrence-free ...
Feb 15, 2017
0
10
